Table 5.
Therapies applied during hospitalization in the studied cohort.
| Variables, Units (N) (CAD/non-CAD) |
Low Risk (0–1) |
Medium Risk (2–3) |
High Risk (>4) |
OMNIBUS p Value |
p Value (For Post Hoc Analysis) |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| n/N (% of Risk Category) |
n/N (% of Risk Category) |
n/N (% of Risk Category) |
||||||||
| CAD | Non- CAD |
CAD | Non- CAD |
CAD | Non- CAD |
CAD | Non- CAD |
CAD | Non- CAD |
|
| Applied Treatment and Procedures | ||||||||||
|
Systemic corticosteroid (228/1955) |
7/12 (58.33%) |
701/1405 (49.89%) |
42/72 (58.33%) |
204/420 (48.57%) |
75/144 (52.08%) |
67/130 (51.54%) |
0.6586 | 0.8145 | N/A | N/A |
|
Convalescent plasma (228/1955) |
2/12 (16.67%) |
165/1405 (11.74%) |
10/72 (13.89%) |
31/420 (7.38%) |
17/144 (11.81%) |
14/130 (10.77%) |
0.6959 | 0.0404 | N/A |
0.0436a 1.0 b 0.8831 c |
|
Tocilizumab (228/1955) |
0/12 (0%) |
22/1405 (1.57%) |
0/72 (0%) |
2/420 (0.48%) |
0/144 (0%) |
1/130 (0.77%) |
1.0 | 0.1866 | N/A | N/A |
|
Remdesivir (228/1955) |
2/12 (16.67%) |
234/1405 (16.65%) |
10/72 (13.89%) |
62/420 (14.76%) |
22/144 (15.28%) |
13/130 (10.0%) |
0.9042 | 0.1109 | N/A | N/A |
|
Antibiotic (228/1955) |
8/12 (66.67%) |
738/1405 (52.53%) |
52/72 (72.22%) |
251/420 (59.76%) |
107/144 (74.31%) |
84/130 (64.62%) |
0.765 | 0.0023 | N/A |
0.0318a 0.0321b 1.0 c |
Categorized variables are presented as a number with a percentage. Information about the numbers with valid values is provided in the left column. Abbreviations: CAD—coronary artery disease, OMNIBUS—analysis of variance, N—valid measurements, n—number of patients with parameter above cut-off point, SD—standard deviation, N/A—non-applicable, a—low risk vs. medium risk, b—low risk vs. high risk, c—medium risk vs. high risk.